VERADIGM INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 21 rows in 2005. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2005-08-01: Reporting owner Thierer Mark; Form 4/A; Security Employee Stock Option (right to buy); Transaction X Exercise of in-the-money or at-the-money derivative security.
- 2005-08-01: Reporting owner Thierer Mark; Form 4/A; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2005-08-01: Reporting owner Thierer Mark; Form 4/A; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2005-07-29: Reporting owner Thierer Mark; Form 4/A; Security Employee Stock Option (right to buy); Transaction X Exercise of in-the-money or at-the-money derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2005-08-01 | Thierer Mark Officer (President, Physicians Interact) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −9,416 75,000 owned after | $7.73 exercise price | 2006-04-26 | |
| 2005-08-01 | Thierer Mark Officer (President, Physicians Interact) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,250 18,750 owned after | $10.25 exercise price | 2006-04-26 | |
| 2005-08-01 | Thierer Mark Officer (President, Physicians Interact) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,334 16,666 owned after | $10.67 exercise price | 2006-04-26 | |
| 2005-07-29 | Thierer Mark Officer (President, Physicians Interact) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −37,500 37,500 owned after | $7.73 exercise price | 2006-04-26 | |
| 2005-07-29 | Thierer Mark Officer (President, Physicians Interact) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −15,584 84,416 owned after | $7.73 exercise price | 2006-04-26 | |
| 2005-03-02 | CULL JOHN G Officer (President, Medication Services) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 0 owned after | $2.34 exercise price | 2006-04-26 | |
| 2005-03-02 | CULL JOHN G Officer (President, Medication Services) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 0 owned after | $0.06 exercise price | 2006-04-26 | |
| 2005-03-02 | MCGRAW LAURIE Officer (President, Clinical Solutions) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +32,401 5,307 owned after | $3.15 exercise price | 2006-04-26 | |
| 2005-03-02 | MCGRAW LAURIE Officer (President, Clinical Solutions) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +5,307 0 owned after | $3.15 exercise price | 2006-04-26 | |
| 2005-03-02 | DAVIS WILLIAM J Officer (Chief Financial Officer) | 4/A | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −39,086 130,000 owned after | $3.04 exercise price | 2006-04-26 | |
| 2005-03-02 | SHAPIRO LEE Officer (President) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −69,797 25,000 owned after | $3.15 exercise price | 2006-04-26 | |
| 2005-03-01 | MCGRAW LAURIE Officer (President, Clinical Solutions) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +12,292 37,708 owned after | $3.15 exercise price | 2006-04-26 | |
| 2005-03-01 | MCGRAW LAURIE Officer (President, Clinical Solutions) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +13,334 6,666 owned after | $2.00 exercise price | 2006-04-26 | |
| 2005-03-01 | DAVIS WILLIAM J Officer (Chief Financial Officer) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,914 169,086 owned after | $3.04 exercise price | 2006-04-26 | |
| 2005-03-01 | SHAPIRO LEE Officer (President) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −55,203 94,797 owned after | $3.15 exercise price | 2006-04-26 | |
| 2005-02-28 | CULL JOHN G Officer (President, Medication Services) | 4/A | Exployee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 2,500 owned after | $2.34 exercise price | 2006-04-26 | |
| 2005-02-28 | CULL JOHN G Officer (President, Medication Services) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,419 2,500 owned after | $0.06 exercise price | 2006-04-26 | |
| 2005-02-25 | CULL JOHN G Officer (President, Medication Services) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 7,500 owned after | $2.34 exercise price | 2006-04-26 | |
| 2005-02-25 | CULL JOHN G Officer (President, Medication Services) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,579 5,919 owned after | $0.06 exercise price | 2006-04-26 | |
| 2005-02-23 | CULL JOHN G Officer (President, Medication Services) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,666 0 owned after | $1.50 exercise price | 2006-04-26 | |
| 2005-02-23 | CULL JOHN G Officer (President, Medication Services) | 4/A | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,383 0 owned after | $1.50 exercise price | 2006-04-26 |